OpenScience.ink

1 week ago • Journal of clinical medicine

Body Weight and Metabolism Changes During Semaglutide and Tirzepatide Treatment in People from Türkiye Over TimeBody Weight Changes and Exploratory Metabolic Outcomes During Semaglutide and Tirzepatide Treatment: A Real-World Longitudinal Cohort Study from Türkiye.

📖 Top 20% JournalArticle

1 week ago • Pharmaceuticals (Basel, Switzerland)

How Plant Compounds Affect Blood Sugar After Eating by Targeting Digestive Enzymes and Blood Sugar-Regulating HormonesPlant-Derived Control of Postprandial Glycemia: α-Amylase, α-Glucosidase, and the Incretin-DPP-4 Interface.

📖 Top 20% JournalArticle

1 week ago • Journal of clinical medicine

Weight Loss Amount, Fat Loss, and Muscle Loss Measured by Device During Obesity TreatmentWeight-Loss Magnitude, Fat Mass, and Device-Estimated Muscle Mass Loss During Obesity Pharmacotherapy.

📖 Top 20% JournalArticle

1 week ago • Frontiers in pharmacology

What people in Saudi Arabia know, think, and do about using GLP-1 receptor agonist medicinesKnowledge, attitudes, and practices among users of GLP-1 receptor agonists in Saudi Arabia: a cross-sectional study.

📖 Top 20% JournalArticle

1 week ago • Journal of clinical medicine

Semaglutide and Similar Diabetes Drugs: Possible Links to Papillary Thyroid Cancer Risk and GrowthSemaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms.

📖 Top 20% JournalArticle

1 week ago • Cells

Tirzepatide reduces lung blood vessel changes in pulmonary arterial hypertension linked to the SIRT1/H4K12la/c-Jun pathwayTirzepatide Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension: Association with the SIRT1/H4K12la/c-Jun Axis.

🎖️ Top 10% JournalArticle

1 week ago • Journal of cardiovascular development and disease

Changes in Heart Metabolism Related to Obesity and Fat Around the Heart in Atrial Fibrillation with New Diabetes Drugs and Catheter TreatmentCardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation.

📖 Top 30% JournalArticle

1 week ago • Frontiers in pharmacology

Tirzepatide compared to other diabetes treatments and the risk of lung flare-ups in people with type 2 diabetes and COPDTirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study.

📖 Top 20% JournalArticle

1 week ago • Frontiers in endocrinology

GLP-1 receptor drugs and lymphedema: from weight loss to possible direct effects on lymph fluid drainageGLP-1 receptor agonists and lymphedema: from weight loss to potential direct modulation of lymphatic function.

🎖️ Top 10% JournalArticle

1 week ago • Open forum infectious diseases

How Long Semaglutide's Benefits Last After Stopping Treatment in Fat Buildup Linked to HIVDurability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial.

🎖️ Top 10% JournalClinical Trial

1 week ago • Comprehensive physiology

Semaglutide changes the gut microbiome beyond reducing appetite with different gut-brain effects in males and femalesSemaglutide Remodels the Gut Microbiome Beyond Its Appetite-Suppressing Action: Sex-Specific Gut-Brain Axis Implications.

🎖️ Top 10% JournalArticle

1 week ago • Frontiers in endocrinology

Periostin’s role, markers, and treatment possibilities in diabetic kidney diseasePeriostin in diabetic kidney disease: mechanistic insights, biomarkers, and therapeutic perspectives.

🎖️ Top 10% JournalArticle

1 week ago • ACS nano

Using mRNA Nanoparticles Delivered to the Gut for Whole-Body Vaccines and Metabolic TreatmentTargeted Gastrointestinal Delivery of mRNA Lipid Nanoparticles Enables Systemic Vaccination and Glucagon-like Peptide-1 Metabolic Therapy.

🥈 Top 2% JournalArticle

1 week ago • Frontiers in endocrinology

Molecular signals linking tissue problems to whole-body insulin resistanceMolecular signaling networks that connect tissue dysfunction to systemic insulin resistance.

🎖️ Top 10% JournalArticle

1 week ago • Molecular pharmaceutics

A Modified GLP-1R Activator Improves Blood Sugar Control in Tumor-Bearing Rats Without Worsening Appetite Loss or Weight LossA Dicyanocobinamide Conjugate of the GLP-1R Agonist Exendin-4 Improves Glucose Homeostasis in Tumor-Bearing Rats without Exacerbating Anorexia and Weight Loss.

📖 Top 20% JournalArticle

2 weeks ago • Diabetology & metabolic syndrome

Effectiveness and safety of mazdutide compared to dulaglutide in adults with type 2 diabetesEfficacy and safety of mazdutide vs. dulaglutide in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

📖 Top 20% JournalArticle

2 weeks ago • Frontiers in endocrinology

Safety, timing, lasting effects, and body changes of weight-loss drugs during cosmetic surgeryGlucagon-like peptide-1 receptor agonists and aesthetic surgery: perioperative safety, timing, durability and body composition.

🎖️ Top 10% JournalArticle

2 weeks ago • Frontiers in endocrinology

How Gut Hormones Affect Bone Health: Molecular Details and Medical ImportanceThe incretin-bone axis: molecular mechanisms and clinical implications.

🎖️ Top 10% JournalArticle

2 weeks ago • Frontiers in endocrinology

Accuracy, harm, weight bias, and commercial influence in short social media posts about obesity drugsAccuracy, potential harm, weight stigma, and commercial influence in short-form social media content on incretin-based therapies for obesity.

🎖️ Top 10% JournalArticle

2 weeks ago • Molecules (Basel, Switzerland)

How Food Processing and Digestion Influence Natural GLP-1 Hormone Release from Gut CellsFrom Food Structure to L-Cell Exposure: How Processing and Digestion Shape Endogenous GLP-1 Responses.

📖 Top 20% JournalArticle

2 weeks ago • Cells

Changes in the GDF-15/GFRAL System and Sensitive Periods After Weight-Loss Surgery: Body, Gut Bacteria, and Drug PerspectivesGDF-15/GFRAL Axis Dynamics and Vulnerability Windows in Bariatric Surgery: Pathophysiological, Microbiomic, and Pharmacological Perspectives.

🎖️ Top 10% JournalArticle

2 weeks ago • Nutrients

Fructooligosaccharide intake is linked to better insulin resistance, lower levels of Romboutsia ilealis bacteria, and changes in GLP-1 hormone in obese mice on a high-fat dietDietary Fructooligosaccharide Is Associated with Improved Insulin Resistance, Reduced Romboutsia ilealis Abundance, and Modulation of GLP-1 Production in High-Fat Diet-Induced Obese Mice.

🎖️ Top 10% JournalArticle

2 weeks ago • Journal of clinical medicine

Anti-Obesity Drugs Compared to Weight-Loss Surgery for Becoming Eligible for Heart Transplant in Patients with Heart PumpsAnti-Obesity Medications Versus Metabolic Bariatric Surgery as Pathways to Heart Transplant Eligibility in LVAD-Supported Patients: A Narrative Review.

📖 Top 20% JournalArticle

2 weeks ago • Journal of clinical medicine

How Fat Tissue Problems May Be Linked to Blood Clots in VeinsFrom Adipose Tissue Dysfunction to Venous Thromboembolism.

📖 Top 20% JournalArticle

2 weeks ago • Cells

Possible Overlap Between GLP-1 Receptor Signals and Liver Cell Protein TAZ in Metabolic Liver Disease: From Metabolism Balance to Liver ScarringPotential Physiological Convergence Between GLP-1 Receptor Signaling and Hepatocyte TAZ in Metabolic Liver Disease: From Metabolic Homeostasis to Fibrotic Remodeling.

🎖️ Top 10% JournalArticle

2 weeks ago • Nutrients

How Gut-Targeting GLP-1 Drugs, Gut Bacteria, and Nutrition May Influence Long-Term Pain Through the Gut-Brain LinkGLP-1 Receptor Agonists, Gut Microbiota, and Chronic Pain: Nutritional Signaling at the Gut-Brain Axis.

🎖️ Top 10% JournalArticle

2 weeks ago • Diabetologia

Differences in Glucagon and GIP Hormone Responses After Pregnancy Diabetes in South Asian and Nordic WomenAltered glucagon and GIP responses in South Asian versus Nordic women after gestational diabetes mellitus.

🥈 Top 2% JournalArticle

2 weeks ago • Nutrients

Tirzepatide for Weight Regain After Weight-Loss Surgery: Focus on Sleeve Gastrectomy, Nutrition Safety, and Medical ConsiderationsTirzepatide for Weight Recurrence After Metabolic and Bariatric Surgery: A Critical Review of Direct and Indirect Evidence with Emphasis on Sleeve Gastrectomy, Nutritional Safety, and Clinical Implications.

🎖️ Top 10% JournalArticle

2 weeks ago • Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Removing Intestinal MSTN May Increase GLP-1 Release by Changing SGLT1 FunctionLoss of Intestinal MSTN Promotes GLP-1 Secretion Through SGLT1 Palmitoylation.

🥈 Top 2% JournalArticle

2 weeks ago • Frontiers in pharmacology

Side effect patterns of semaglutide and liraglutide for different uses based on safety report analysisIndication-specific adverse event profiles of semaglutide and liraglutide: a FAERS disproportionality analysis.

📖 Top 20% JournalArticle

← prevpage 3 of 16next →

GLP-1 Therapies Research Papers